These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 8757017)
1. Apolipoprotein E epsilon 4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease. Kurz A; Egensperger R; Haupt M; Lautenschlager N; Romero B; Graeber MB; Müller U Neurology; 1996 Aug; 47(2):440-3. PubMed ID: 8757017 [TBL] [Abstract][Full Text] [Related]
2. No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease. Murphy GM; Taylor J; Kraemer HC; Yesavage J; Tinklenberg JR Am J Psychiatry; 1997 May; 154(5):603-8. PubMed ID: 9137113 [TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. Dal Forno G; Rasmusson DX; Brandt J; Carson KA; Brookmeyer R; Troncoso J; Kawas CH Arch Neurol; 1996 Apr; 53(4):345-50. PubMed ID: 8929157 [TBL] [Abstract][Full Text] [Related]
4. APOE genotype: no influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease. Aerssens J; Raeymaekers P; Lilienfeld S; Geerts H; Konings F; Parys W Dement Geriatr Cogn Disord; 2001; 12(2):69-77. PubMed ID: 11173877 [TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein epsilon 4 allele and disease progression in patients with late-onset Alzheimer's disease. Basun H; Grut M; Winblad B; Lannfelt L Neurosci Lett; 1995 Jan; 183(1-2):32-4. PubMed ID: 7746480 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease. Hashimoto M; Yasuda M; Tanimukai S; Matsui M; Hirono N; Kazui H; Mori E Neurology; 2001 Oct; 57(8):1461-6. PubMed ID: 11673590 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Growdon JH; Locascio JJ; Corkin S; Gomez-Isla T; Hyman BT Neurology; 1996 Aug; 47(2):444-8. PubMed ID: 8757018 [TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis. Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282 [TBL] [Abstract][Full Text] [Related]
9. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects. Engelborghs S; Dermaut B; Goeman J; Saerens J; Mariën P; Pickut BA; Van den Broeck M; Serneels S; Cruts M; Van Broeckhoven C; De Deyn PP J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1148-51. PubMed ID: 12876259 [TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E epsilon 4, other risk factors, and course of Alzheimer's disease. Weiner MF; Vega G; Risser RC; Honig LS; Cullum CM; Crumpacker D; Rosenberg RN Biol Psychiatry; 1999 Mar; 45(5):633-8. PubMed ID: 10088051 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E (APOE) allele frequencies in late-onset sporadic Alzheimer's disease (AD), mixed dementia and vascular dementia: lack of association of epsilon 4 allele with AD in Italian octogenarian patients. Scacchi R; De Bernardini L; Mantuano E; Donini LM; Vilardo T; Corbo RM Neurosci Lett; 1995 Dec; 201(3):231-4. PubMed ID: 8786847 [TBL] [Abstract][Full Text] [Related]
12. [Genetic association between the apolipoprotein E (ApoE) gene alleles and various forms of Alzheimer's disease]. Korovaĭtseva GI; Shcherbatykh TV; Selezneva NV; Gavrilova SI; Golimbet VE; Voskresenskaia NI; Rogaev EI Genetika; 2001 Apr; 37(4):529-35. PubMed ID: 11421127 [TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E-epsilon 4 allele and familial risk in Alzheimer's disease. Li G; Silverman JM; Altstiel LD; Haroutunian V; Perl DP; Purohit D; Birstein S; Lantz M; Mohs RC; Davis KL Genet Epidemiol; 1996; 13(3):285-98. PubMed ID: 8797010 [TBL] [Abstract][Full Text] [Related]
14. Lack of association of apolipoprotein E allele epsilon 4 with late-onset Alzheimer's disease among Finnish centenarians. Sobel E; Louhija J; Sulkava R; Davanipour Z; Kontula K; Miettinen H; Tikkanen M; Kainulainen K; Tilvis R Neurology; 1995 May; 45(5):903-7. PubMed ID: 7746404 [TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E genotype in the prediction of cognitive decline and dementia in a prospectively studied elderly population. Brayne C; Harrington CR; Wischik CM; Huppert FA; Chi LY; Xuereb JH; O'Connor DW; Paykel ES Dementia; 1996; 7(3):169-74. PubMed ID: 8740632 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E epsilon 4 allele frequency in demented and cognitively impaired patients with and without cerebrovascular disease. Traykov L; Rigaud AS; Baudic S; Smagghe A; Boller F; Forette F J Neurol Sci; 2002 Nov; 203-204():177-81. PubMed ID: 12417380 [TBL] [Abstract][Full Text] [Related]